Skip to main content
. 2017 Feb 10;8:53. doi: 10.3389/fphar.2017.00053

FIGURE 1.

FIGURE 1

(A) Visual analog scale (VAS) pain scale, (B) HAQ-DI, and (C) TRPA1 expression on peripheral blood leukocytes in patients with rheumatoid arthritis (RA) treated or not with either leflunomide (LFN; n = 15) or adalimumab (ADA; n = 15), in comparison with patients recently diagnosed with RA but not yet receiving specific treatment with anti-rheumatic drugs (NST group; n = 10) and healthy subjects (n = 15). Data are expressed as mean ± SD. (D) Scatter plot for TRPA1 correlation with VAS pain scale and HAQ-DI. p < 0.05, differs from healthy subjects; #p < 0.05, differs from the NST group.